Cyclarity Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $6M

  • Investors
  • 13

Cyclarity Therapeutics General Information

Description

Developer of compound-based drugs designed to treat the underlying causes of age-related diseases. The company's drugs offer simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules to remove arterial plaque by clearing the non-degradable cholesterol, enabling clinicians to provide patients with disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.

Contact Information

Formerly Known As
Underdog Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8001 Redwood Boulevard
  • Novato, CA 94945
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 8001 Redwood Boulevard
  • Novato, CA 94945
  • United States
+1 (650)

Cyclarity Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cyclarity Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 25-Mar-2026 $6M Completed Clinical Trials - Phase 1
5. Later Stage VC 17-Dec-2024 Completed Pre-Clinical Trials
4. Seed Round 23-Sep-2021 Completed Pre-Clinical Trials
3. Grant 05-Sep-2021 Completed Pre-Clinical Trials
2. Seed Round 14-Nov-2019 $3.95M $7.73M Completed Pre-Clinical Trials
1. Accelerator/Incubator $3.78M $3.78M Completed Pre-Clinical Trials
To view Cyclarity Therapeutics’s complete valuation and funding history, request access »

Cyclarity Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-3
Series A-2
Series A-1
Seed II 9,654,367 $0.000010 8% $1.04 $1.04 1x $0.91 24.35%
Seed 4,536,844 $0.000010 8% $0.87 $0.87 1x $0.81 10.79%
To view Cyclarity Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cyclarity Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of compound-based drugs designed to treat the underlying causes of age-related diseases. The company's drugs o
Drug Discovery
Novato, CA
11 As of 2026

Burlington, MA
 

King of Prussia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cyclarity Therapeutics Competitors (4)

One of Cyclarity Therapeutics’s 4 competitors is Cardurion, a Venture Capital-Backed company based in Burlington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardurion Venture Capital-Backed Burlington, MA
XyloCor Therapeutics Venture Capital-Backed King of Prussia, PA
Renova Therapeutics Venture Capital-Backed Carlsbad, CA
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
To view Cyclarity Therapeutics’s complete competitors history, request access »

Cyclarity Therapeutics Patents

Cyclarity Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023533745-A Cyclodextrin dimer and use thereof Active 07-Jul-2020
JP-2026120622-A Cyclodextrin dimers and their use Pending 07-Jul-2020
JP-7851622-B2 Cyclodextrin dimers and their use Active 07-Jul-2020
AU-2021306298-A1 Cyclodextrin dimers and uses thereof Pending 07-Jul-2020
CA-3184962-A1 Cyclodextrin dimers and uses thereof Pending 07-Jul-2020 C08B37/0012
To view Cyclarity Therapeutics’s complete patent history, request access »

Cyclarity Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cyclarity Therapeutics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cistern Capital Venture Capital Minority
Immortal Dragons Venture Capital Minority
Ki Tua Fund Corporate Venture Capital Minority
Seed Healthcare Venture Capital Minority
Starbloom Capital Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Cyclarity Therapeutics FAQs

  • When was Cyclarity Therapeutics founded?

    Cyclarity Therapeutics was founded in 2019.

  • Where is Cyclarity Therapeutics headquartered?

    Cyclarity Therapeutics is headquartered in Novato, CA.

  • What is the size of Cyclarity Therapeutics?

    Cyclarity Therapeutics has 11 total employees.

  • What industry is Cyclarity Therapeutics in?

    Cyclarity Therapeutics’s primary industry is Drug Discovery.

  • Is Cyclarity Therapeutics a private or public company?

    Cyclarity Therapeutics is a Private company.

  • What is Cyclarity Therapeutics’s current revenue?

    The current revenue for Cyclarity Therapeutics is .

  • How much funding has Cyclarity Therapeutics raised over time?

    Cyclarity Therapeutics has raised $34M.

  • Who are Cyclarity Therapeutics’s investors?

    Cistern Capital, Immortal Dragons, Ki Tua Fund, Seed Healthcare, and Starbloom Capital are 5 of 13 investors who have invested in Cyclarity Therapeutics.

  • Who are Cyclarity Therapeutics’s competitors?

    Cardurion, XyloCor Therapeutics, Renova Therapeutics, and Dicerna Pharmaceuticals are competitors of Cyclarity Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process